Skip to content

Clinical trials

Phase 4 Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 4 Clear all

205 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20025
20037
20048
20054
200610
20076
20089
200911
201010
201110
201211
201310
20148
20158
20167
20178
20188
20198
20206
202113
20224
202310
20247
20253
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed113
Unknown status39
Terminated16
Recruiting16
Withdrawn9
Active, not recruiting7
Not yet recruiting4
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Merck Sharp & Dohme LLC4
Grupo de Apoio ao Adolescente e a Crianca com Cancer3
Hoffmann-La Roche3
Mundipharma Korea Ltd3
Radboud University Medical Center3
Sanofi3
Shenzhen SiBiono GeneTech Co.,Ltd3
ActiViews Ltd.2
Amgen2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms205
Pain15
Anemia9
Breast Neoplasms9
Cancer Pain9
Neutropenia8
Prostatic Neoplasms8
Febrile Neutropenia7
Vomiting7
Stomach Neoplasms6

Trials

Showing 51 to 75 of 205. Each trial links to its page on Pharma Observatory.

105 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.